RU58841 Powder

Buy RU58841 Powder Online

RU58841 is a nonsteroidal antiandrogen developed for topical inhibition of androgen-receptor activity. It has attracted considerable research interest in androgen-dependent skin and hair conditions, particularly androgenetic alopecia.

Product Information

RU58841 competes with androgens at the androgen receptor. Experimental research has demonstrated suppression of androgen-dependent signaling in human prostate cells and activity against hair-growth effects in animal models.

How It Works

RU58841 acts as an androgen-receptor antagonist, reducing the ability of testosterone-derived androgens such as DHT to activate the receptor. Its intended research application has primarily involved local rather than systemic androgen blockade.

POTENTIAL BENEFITS

1. Androgen-Receptor Research

RU58841 directly targets androgen-receptor signaling, making it a useful research compound for understanding how androgen activity affects skin, hair follicles, and other androgen-responsive tissues.

2. Hair-Loss Research

Animal studies have investigated RU58841 as a topical antiandrogen for androgen-dependent hair loss. Its local receptor activity is the principal reason it has become associated with hair-regrowth research.

3. DHT-Signaling Modulation

Rather than reducing testosterone production directly, RU58841 works downstream by interfering with androgen-receptor activation. This provides a mechanistically distinct approach to androgen signaling.

4. Nonsteroidal Antiandrogen

RU58841 is structurally distinct from steroidal antiandrogens. Laboratory studies demonstrated competitive suppression of DHT-driven androgen-receptor activation.

Dosage

There is no established human therapeutic dosage for RU58841. Historical research has focused primarily on topical experimental administration, including animal models. Online dosing practices should not be presented as clinically validated human dosing.

Side Effects

Human safety data are inadequate. Potential concerns include local irritation and unpredictable systemic antiandrogenic effects if absorption occurs. The long-term safety of unsupervised topical use has not been established.

References

1. Sintov A, et al. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stump-tailed macaques. Endocrine. 1998;9(1):39-43. PMID: 9798729. PubMed
2. Miyamoto H, et al. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci USA. 1998;95(13):7379-7384. PMID: 9636157. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.